Presentation Request • Access Archive
• FAQ Sheet
You Have Another Chance to Take Advantage
of the content from the recent webinar:
Oncology Market Access Europe: Bridging the Gap Between Regulatory Approval and Product Adoption
The presentation is also available free, for your continued reference.
FAQ Sheet
Access a comprehensive PDF with the questions and answers from this event.
THE ONDEMAND IS READY!
The OnDemand version of the "Oncology Market Access Europe: Bridging the Gap Between Regulatory Approval and Product Adoption" web cast presented on February 25, 2009 is now available for viewing. This event is brought to you by PharmaVOICE and sponsored by MattsonJack. Please see below for important event information.
To Access the Archive, go to http://www.pharmavoice.com/omaeurope
TECHNICAL SUPPORT
Help Desk is staffed from 8:00 am to 8:00 pm ET Monday - Friday.
Call 800-763-3978 for assistance and reference project #00232-1.
System Requirements
Macromedia Flash Player 8.0 or higher
Internet Connection
Computer with sound card, internet connection, and speakers
Recommended screen resolution: 1024x768
About MattsonJack:
Formed in 1986, The Mattson Jack Group, Inc. (MattsonJack), a Kantar Healthcare company, is a global consulting firm devoted exclusively to the pharmaceutical and biotech industries. We combine a strong commercial orientation with a scientific focus to provide innovative solutions to our clients' business challenges in virtually every therapeutic area. MattsonJack consultants have expertise in pricing and reimbursement, custom epidemiology, technology assessment, business and strategic plan development, due diligence and licensing support, market modeling and forecasting, and primary market research. MattsonJack supports its clients' interests through its custom consulting and multiclient offerings, including Epi Database®, Forecast Architect®, CancerNFluence®, Oncology Marketing Strategies U.S., Oncology Market Access Europe, and CancerMPact®.
To qualify for a FREE subscription to PharmaVOICE magazine, visit: http://www.pharmavoice.com/subscription
If you do not wish to receive PharmaVOICE WebLinx announcements and updates, please unsubscribe here. If you do not wish to receive All PharmaVOICE e-mails, unsubscribe here. If the link is not working, please forward this e-mail to feedback@pharmavoice.com and type UNSUBSCRIBE Third Party in the subject line or please send a letter including your name, request for removal, and e-mail address to: PharmaVOICE, P.O. Box 327, Titusville, NJ 08560.